Nasdaq

CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy

REHOVOT, Israel and BETHESDA, MD., Oct. 18, 2022 /PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced ...
Seeking Alpha

Lantern Pharma Announces PCT Patent Application Publication for Innovative, High Performing, Machine Learning Model for Predicting Blood Brain Barrier Permeability of Drug ...

DALLAS--(BUSINESS WIRE)-- Lantern Pharma Inc. (LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology drug ...
Business Wire

Devonian Files Patent Cooperation Treaty (PCT) Application for Thykamine™ in Wound Healing

QUÉBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD; OTCQB: DVHGF), a clinical stage botanical pharmaceutical corporation, focused on developing a ...
Business Insider

Terran Biosciences announces publication of PCT patent application covering novel orally active forms of psilocin with improved pharmacokinetic properties

NEW YORK, Feb. 24, 2023 /PRNewswire/ -- Terran Biosciences ("Terran"), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric ...
The Globe and Mail

Adial Pharmaceuticals Announces Publication of International PCT Patent Application to Protect Core Assets and Extend IP Exclusivity to at least 2045

GLEN ALLEN, Va., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for ...